Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

Journal of Hepatology

Volumn 56, Issue 4, 2012, Pages 788-794

  Neukam, Karin ^a   Camacho, Angela ^b   Caruz, Antonio ^c   Rallón, Norma ^d   Torres Cornejo, Almudena ^e,f   Rockstroh, Jürgen K ^g   MacÍas, Juan ^a   Rivero, Antonio ^b   Benito, José M ^d   López Cortés, Luis F ^e,f   Nattermann, Jacob ^g   Gómez Mateos, Jesús ^a   Soriano, Vicente ^d   Pineda, Juan A ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c UNIVERSITY OF JAÉN   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f Instituto de Biomedicina de Sevilla   (Spain)

^g UNIVERSITY OF BONN   (Germany)

Author keywords

Genotype; Hepatitis C; Interferon; Interleukin 28B; Ribavirin

Indexed keywords

INTERLEUKIN 28B; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ADULT; ALGORITHM; ARTICLE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS LOAD;

ADULT; ALGORITHMS; ANTIVIRAL AGENTS; COHORT STUDIES; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; INTERLEUKINS; MALE; MIDDLE AGED; MODELS, STATISTICAL; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84858706070     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.11.008     Document Type: Article

References (27)

1. M.J. Alter Epidemiology of viral hepatitis and HIV co-infection J Hepatol 44 2006 S6 S9 (Pubitemid 43053865)
2. R. Weber, C.A. Sabin, N. Friis-Møller, P. Reiss, W.M. El-Sadr, and O. Kirk Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study Arch Intern Med 166 2006 1632 1641 (Pubitemid 44232373)
3. J.A. Pineda, J.A. García-García, M. Aguilar-Guisado, M.J. Ríos-Villegas, J. Ruiz-Morales, and A. Rivero Clinical progression of Hepatitis C Virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy Hepatology 46 2007 622 630 (Pubitemid 47436106)
4. J. Macías, J. del Valle, A. Rivero, J.A. Mira, A. Camacho, and N. Merchante Changes in liver stiffness in patients with chronic hepatitis C with and without human immunodeficiency virus coinfection treated with pegylated interferon plus ribavirin J Antimicrob Chemother 65 2010 2204 2211
5. J. Berenguer, J. Alvarez-Pellicer, P.M. Martín, J. López-Aldeguer, M.A. Von-Wichmann, and C. Quereda Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus Hepatology 50 2009 407 413
6. F.J. Torriani, M. Rodriguez-Torres, J.K. Rockstroh, E. Lissen, J. González-García, and A. Lazzarin Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450 (Pubitemid 38988593)
7. J.A. Pineda, J.A. Mira, I.L. Gil, B. Valera-Bestard, A. Rivero, and D. Merino Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients J Antimicrob Chemother 60 2007 1347 1354 (Pubitemid 350168332)
8. F. Carrat, F. Bani-Sadr, S. Pol, E. Rosenthal, F. Lunel-Fabiani, and A. Benzekri Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial JAMA 292 2004 2839 2848 (Pubitemid 39628231)
9. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and F.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
10. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, and N. Sakamoto Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
11. V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, and M.L. Abate IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
12. A. Rauch, Z. Kutalik, P. Descombes, T. Cai, J. Di Iulio, and T. Mueller Genetic variation in IL28B is associated with chronic hepatitis C and treatment tailure - A genome-wide association study Gastroenterology 138 2010 1338 1345
13. J.A. Pineda, A. Caruz, A. Rivero, K. Neukam, I. Salas, and A. Camacho Variation in interleukin 28B gene predicts response to pegylated interferon plus ribavirin in human immunodeficiency virus/hepatitis C virus-coinfected patients Clin Infect Dis 51 2010 788 795
14. N. Rallón, S. Naggie, J.M. Benito, J. Medrano, C. Restrepo, and D. Goldstein Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus co-infected patients AIDS 24 2010 F23 F29
15. J. Medrano, K. Neukam, N. Rallón, A. Rivero, S. Resino, and S. Naggie Modeling the probability of sustained virological response to Therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV Clin Infect Dis 51 2010 1209 1216
16. M. Sulkowski, D. Dieterich, K. Sherman, J. Rockstroh, N. Adda, and L. Mahnke Program and abstracts of the 18th conference on retroviruses and opportunistic infections (Boston) 2011 Boston USA
17. L.F. López-Cortés, B. Valera-Bestard, A. Gutiérrez-Valencia, R. Ruiz-Valderas, L. Jiménez, and A. Arizcorreta Role of pegylated interferon-alpha-2a and ribavirin concentrations in sustained viral response in HCV/HIV-coinfected patients Clin Pharmacol Ther 84 2008 573 580
18. H.D. Nischalke, M. Vogel, S. Mauss, A. Baumgarten, T. Lutz, and M. Danta The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infection AIDS 24 2010 2001 2007
19. European AIDS Clinical Society. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. Available from: http://www. europeanaidsclinicalsociety.org/guidelinespdf/3-Chronic-HepatitisB-&-C.pdf [accessed July 2011].
20. V. Soriano, M. Puoti, M. Sulkowski, A. Cargnel, Y. Benhamou, and M. Peters Care of patients with hepatitis C and HIV co-infection AIDS 18 2004 1 12 (Pubitemid 38402312)
21. J. Macías, J. Berenguer, M.A. Japón, J.A. Girón, A. Rivero, and L.F. López-Cortés Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus Hepatology 50 2009 1056 1063
22. V. Soriano, A. Mocroft, J. Rockstroh, B. Ledergerber, B. Knysz, and S. Chaplinskas EuroSIDA Study Group. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe J Infect Dis 198 2008 1337 1344
23. J.A. Mira, B. Valera-Bestard, A. Arizcorreta-Yarza, M. González-Serrano, J. Torre-Cisneros, and I. Santos Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients Antivir Ther 12 2007 523 529 (Pubitemid 47041151)
24. E. Van den Eynde, J.M. Tiraboschi, C. Tural, R. Solà, J.A. Mira, and D. Podzamczer Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients AIDS 24 2010 975 982
25. R. van Heeswijk, A. Vandevoorde, G. Boogaerts, T. Vangeneugden, E. de Paepe, and R. Polo Program and abstracts of the 18th conference on retroviruses and opportunistic infections (Boston) 2011 Boston USA
26. J. Medrano, S. Resino, E. Vispo, A. Madejón, P. Labarga, and P. Tuma Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients J Viral Hepat 18 2011 325 330
27. D. Hüppe, E. Zehnter, S. Mauss, K. Böker, T. Lutz, and S. Racky Epidemiology of chronic hepatitis C in Germany - an analysis of 10,326 patients in hepatitis centres and outpatient units Z Gastroenterol 46 2008 34 44 (Pubitemid 351261948)